Cargando…
“Hemolysis, or not Hemolysis, that is the Question”. Use of Hydroxychloroquine in a Patient with COVID-19 Infection and G6PD Deficiency
Autores principales: | Sgherza, Nicola, Dalfino, Lidia, Palma, Antonio, Vitucci, Angelantonio, Campanale, Daniela, Grasso, Salvatore, Musto, Pellegrino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643778/ https://www.ncbi.nlm.nih.gov/pubmed/33194150 http://dx.doi.org/10.4084/MJHID.2020.076 |
Ejemplares similares
-
No evidence that chloroquine or hydroxychloroquine induce hemolysis in G6PD deficiency()
por: Schilling, William H.K., et al.
Publicado: (2020) -
Can Hydroxychloroquine Cause G6PD-Related Hemolysis? A Case Study
por: Obeidat, Khaldun, et al.
Publicado: (2020) -
Interesting case of G6PD deficiency anemia with severe hemolysis
por: Chhabra, Anupam, et al.
Publicado: (2013) -
Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine is not influenced by AB0 blood group in subjects with transfusion-dependent thalassemia
por: Sgherza, Nicola, et al.
Publicado: (2022) -
Hemolysis and methemoglobinemia due to hepatitis E virus infection in patient with G6PD deficiency
por: Au, Wing Y., et al.
Publicado: (2011)